References
- Adegbite AB, Khan MI, Paine KW, Tan LK : The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58 : 51-56, 1983 https://doi.org/10.3171/jns.1983.58.1.0051
- Blasberg RG, Patlak C, Fenstermacher JD : Intrathecal chemotherapy : brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther 195 : 73-83, 1975
- Chamberlain MC : Adjuvant combined modality therapy for malignant meningiomas. J Neurosurg 84 : 733-736, 1996 https://doi.org/10.3171/jns.1996.84.5.0733
- Chamberlain MC, Glantz MJ : Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas. Cancer 113 : 2146-2151, 2008 https://doi.org/10.1002/cncr.23803
- Chamberlain MC, Glantz MJ, Fadul CE : Recurrent meningioma : salvage therapy with long-acting somatostatin analogue. Neurology 69 : 969-973, 2007 https://doi.org/10.1212/01.wnl.0000271382.62776.b7
- Chamberlain MC, Johnston SK : Hydroxyurea for recurrent surgery and radiation refractory meningioma : a retrospective case series. J Neurooncol 104 : 765-771, 2011 https://doi.org/10.1007/s11060-011-0541-5
- Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL : Benign meningiomas : primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39 : 427-436, 1997 https://doi.org/10.1016/S0360-3016(97)00317-9
- Forbes AR, Goldberg ID : Radiation therapy in the treatment of meningioma : the Joint Center for Radiation Therapy experience 1970 to 1982. J Clin Oncol 2 : 1139-1143, 1984 https://doi.org/10.1200/JCO.1984.2.10.1139
- Goldsmith BJ, Wara WM, Wilson CB, Larson DA : Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80 : 195-201, 1994 https://doi.org/10.3171/jns.1994.80.2.0195
- Gwilt PR, Tracewell WG : Pharmacokinetics and pharmacodynamics of hydroxyurea. Clin Pharmacokinet 34 : 347-358, 1998 https://doi.org/10.2165/00003088-199834050-00002
- Hahn BM, Schrell UM, Sauer R, Fahlbusch R, Ganslandt O, Grabenbauer GG : Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma : results of a pilot study. J Neurooncol 74 : 157-165, 2005 https://doi.org/10.1007/s11060-004-2337-3
- Kaba SE, DeMonte F, Bruner JM, Kyritsis AP, Jaeckle KA, Levin V, et al. : The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B. Neurosurgery 40 : 271-275, 1997 https://doi.org/10.1097/00006123-199702000-00007
- Kallio M, Sankila R, Hakulinen T, Jääskeläinen J : Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31 : 2-12, 1992 https://doi.org/10.1227/00006123-199207000-00002
- Kyritsis AP : Chemotherapy for meningiomas. J Neurooncol 29 : 269-272, 1996 https://doi.org/10.1007/BF00165657
- Lee JH, Kim OL, Kim SH, Bae JH, Choi BY, Cho SH : Hydroxyurea treatment for unresectable and uecurrent meningiomas. J Korean Neurosurg Soc 30 : S120-S123, 2001
- Longstreth WT Jr, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD : Epidemiology of intracranial meningioma. Cancer 72 : 639-648, 1993 https://doi.org/10.1002/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P
- Lori F, Lisziewicz J : Hydroxyurea : overview of clinical data and antiretroviral and immunomodulatory effects. Antivir Ther 4 Suppl 3 : 101-108, 1999
- Loven D, Hardoff R, Sever ZB, Steinmetz AP, Gornish M, Rappaport ZH, et al. : Non-resectable slow-growing meningiomas treated by hydroxyurea. J Neurooncol 67 : 221-226, 2004 https://doi.org/10.1023/B:NEON.0000021827.85754.8e
- Martin DS, Stolfi RL, Colofiore JR : Perspective : the chemotherapeutic relevance of apoptosis and a proposed biochemical cascade for chemotherapeutically induced apoptosis. Cancer Invest 15 : 372-381, 1997 https://doi.org/10.3109/07357909709039742
- Mason WP, Gentili F, Macdonald DR, Hariharan S, Cruz CR, Abrey LE : Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. J Neurosurg 97 : 341-346, 2002 https://doi.org/10.3171/jns.2002.97.2.0341
- Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ : Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 34 : 817-822, 1996 https://doi.org/10.1016/0360-3016(95)02166-3
- Miralbell R, Linggood RM, de la Monte S, Convery K, Munzenrider JE, Mirimanoff RO : The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol 13 : 157-164, 1992 https://doi.org/10.1007/BF00172765
- Navarra P, Preziosi P : Hydroxyurea : new insights on an old drug. Crit Rev Oncol Hematol 29 : 249-255, 1999 https://doi.org/10.1016/S1040-8428(98)00032-8
- Newton HB : Handbook of brain tumor chemotherapy. Amsterdam, Boston : Elsevier Medical Publishers/Academic Press, 2006, ppxvi, pp510-524
- Newton HB, Scott SR, Volpi C : Hydroxyurea chemotherapy for meningiomas : enlarged cohort with extended follow-up. Br J Neurosurg 18 : 495-499, 2004 https://doi.org/10.1080/02688690400012392
- Newton HB, Slivka MA, Stevens C : Hydroxyurea chemotherapy for unresectable or residual meningioma. J Neurooncol 49 : 165-170, 2000 https://doi.org/10.1023/A:1026770624783
- Newton HB, Turowski RC, Stroup TJ, McCoy LK : Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors. Ann Pharmacother 33 : 816-832, 1999 https://doi.org/10.1345/aph.18353
- Noiri E, Masaki I, Fujino K, Tsuchiya M : Efficacy of a continuous syringe extraction method for monitoring hemodialysis ultrafiltrate. ASAIO J 46 : 461-463, 2000 https://doi.org/10.1097/00002480-200007000-00019
- Pollock BE, Stafford SL, Utter A, Giannini C, Schreiner SA : Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas. Int J Radiat Oncol Biol Phys 55 : 1000-1005, 2003 https://doi.org/10.1016/S0360-3016(02)04356-0
- Rohringer M, Sutherland GR, Louw DF, Sima AA : Incidence and clinicopathological features of meningioma. J Neurosurg 71 : 665-672, 1989 https://doi.org/10.3171/jns.1989.71.5.0665
- Rosenthal MA, Ashley DL, Cher L : Treatment of high risk or recurrent meningiomas with hydroxyurea. J Clin Neurosci 9 : 156-158, 2002 https://doi.org/10.1054/jocn.2001.1019
- Schrell UM, Rittig MG, Anders M, Kiesewetter F, Marschalek R, Koch UH, et al. : Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 86 : 845-852, 1997 https://doi.org/10.3171/jns.1997.86.5.0845
- Schrell UM, Rittig MG, Anders M, Koch UH, Marschalek R, Kiesewetter F, et al. : Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 86 : 840-844, 1997 https://doi.org/10.3171/jns.1997.86.5.0840
- Simpson D : The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20 : 22-39, 1957 https://doi.org/10.1136/jnnp.20.1.22
- Stearns B, Losee KA, Bernstein J : Hydroxyurea. A new type of potential antitumor agent. J Med Chem 6 : 201, 1963 https://doi.org/10.1021/jm00338a026
- Stewart BW : Mechanisms of apoptosis : integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 86 : 1286-1296, 1994 https://doi.org/10.1093/jnci/86.17.1286
Cited by
- Current standing and frontiers of gene therapy for meningiomas vol.35, pp.6, 2013, https://doi.org/10.3171/2013.8.focus13305
- The importance of microsurgery in childhood meningioma: a case report vol.31, pp.1, 2015, https://doi.org/10.1007/s00381-014-2490-8
- Systemic therapy for recurrent meningioma vol.16, pp.8, 2012, https://doi.org/10.1080/14737175.2016.1184087
- Medical management of meningioma in the era of precision medicine vol.44, pp.4, 2012, https://doi.org/10.3171/2018.1.focus17754
- Medical management of meningioma in the era of precision medicine vol.44, pp.4, 2012, https://doi.org/10.3171/2018.1.focus17754
- Role of hydroxyurea as an adjuvant treatment after Gamma knife radiosurgery for atypical (WHO grade II) meningiomas vol.30, pp.2, 2018, https://doi.org/10.1016/j.jnci.2018.04.001
- Expression of Cathepsins B, D, and G in WHO Grade I Meningioma vol.6, pp.None, 2012, https://doi.org/10.3389/fsurg.2019.00006
- Children’s Cancer and Leukaemia Group (CCLG): review and guidelines for the management of meningioma in children, teenagers and young adults vol.34, pp.2, 2020, https://doi.org/10.1080/02688697.2020.1726286